Selective neuronal vulnerability in Parkinson's disease
- PMID: 32247375
- DOI: 10.1016/bs.pbr.2020.02.005
Selective neuronal vulnerability in Parkinson's disease
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease, disabling millions worldwide. Despite the imperative PD poses, at present, there is no cure or means of slowing progression. This gap is attributable to our incomplete understanding of the factors driving pathogenesis. Research over the past several decades suggests that both cell-autonomous and non-cell autonomous processes contribute to the neuronal dysfunction underlying PD symptoms. The thesis of this review is that an intersection of these processes governs the pattern of pathology in PD. Studies of substantia nigra pars compacta (SNc) dopaminergic neurons, whose loss is responsible for the core motor symptoms of PD, suggest that they have a combination of traits-a long, highly branched axon, autonomous activity, and elevated mitochondrial oxidant stress-that predispose them to non-cell autonomous drivers of pathogenesis, like misfolded forms of alpha-synuclein (α-SYN) and inflammation. The literature surrounding these issues will be briefly summarized, and the translational implications of an intersectional hypothesis of PD pathogenesis discussed.
Keywords: Aging; Axon; Calcium; Lewy pathology; Mitochondrial dysfunction; Neurodegeneration; Oxidant stress; Parkinson's disease; Propagation; Synapse; α-synuclein.
© 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Determinants of dopaminergic neuron loss in Parkinson's disease.FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14. FEBS J. 2018. PMID: 30028088 Free PMC article. Review.
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.Int J Mol Sci. 2019 Oct 25;20(21):5312. doi: 10.3390/ijms20215312. Int J Mol Sci. 2019. PMID: 31731450 Free PMC article. Review.
-
α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.Mol Neurodegener. 2024 Oct 8;19(1):69. doi: 10.1186/s13024-024-00756-2. Mol Neurodegener. 2024. PMID: 39379975 Free PMC article.
-
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease.J Mol Biol. 2023 Jun 15;435(12):167992. doi: 10.1016/j.jmb.2023.167992. Epub 2023 Feb 2. J Mol Biol. 2023. PMID: 36736886 Review.
Cited by
-
Predicting longitudinal brain atrophy in Parkinson's disease using a Susceptible-Infected-Removed agent-based model.Netw Neurosci. 2023 Oct 1;7(3):906-925. doi: 10.1162/netn_a_00296. eCollection 2023. Netw Neurosci. 2023. PMID: 37781140 Free PMC article.
-
Mechanisms of pacemaking in mammalian neurons.J Physiol. 2024 Sep 20:10.1113/JP284759. doi: 10.1113/JP284759. Online ahead of print. J Physiol. 2024. PMID: 39303139 Review.
-
A primate nigrostriatal atlas of neuronal vulnerability and resilience in a model of Parkinson's disease.Nat Commun. 2023 Nov 18;14(1):7497. doi: 10.1038/s41467-023-43213-2. Nat Commun. 2023. PMID: 37980356 Free PMC article.
-
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.Brain. 2023 Aug 1;146(8):3301-3318. doi: 10.1093/brain/awad044. Brain. 2023. PMID: 36826230 Free PMC article.
-
Parkinson's Disease: A Tale of Many Players.Med Princ Pract. 2023;32(3):155-165. doi: 10.1159/000531422. Epub 2023 Jun 7. Med Princ Pract. 2023. PMID: 37285828 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous